Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Arch Esp Urol ; 75(8): 693-699, 2022 Oct.
Article in English | MEDLINE | ID: mdl-36330570

ABSTRACT

INTRODUCTION: Voiding urosonography (VUS) is a dynamic imaging technique which evaluates the lower urinary tract by introducing sonographic contrast into the bladder, preferably used in the diagnosis of vesicoureteral reflux (VUR). Our goals were to describe the clinical indications for performing a VUS for VUR's diagnosis and analyse its diagnostic reliability. MATERIAL AND METHODS: Cross-sectional study carried on patients under 15 years old with a VUS taken between November 2013-2020. Sex, age, indications (lower urinary tract infection-LUTI; dilatated lower urinary tract-DLUT; duplex collecting system-DCS), results (presence/absence of VUR, score and side) and complications were analysed. U Mann-Whitney and Chi-squared tests were used and 2 predictive capacity models for the indications used to detect VUR were employed (logistic binomial regression and multilayer perceptron neural network). Statistical significance p < 0.05. RESULTS: 415 VUS were completed correctly (male 51.8%, median age 7.3 (3.1-15.3) months). Indications were: LUTI (67.5%), DLUT (33.5%) and DCS (10.2%); presenting 1, 2 and 3 indications in 86.5%, 12.8% and 0.7% respectively. VUR was diagnosed in 34.7% cases. A tendency towards statistically significance was showed related to male sex (p = 0.052) and the only significative clinical indication for VUR was DCS (p = 0.007). Patients with 2 simultaneous indications had higher probability of VUR (p = 0.012). DCS presence or male sex were the only predictive variables of VUR: DCS = OR 1.89 (1.54-6.52) (p = 0.006) and male sex = OR 1.56 (1.03-2.35) (p = 0.035). CONCLUSIONS: VUS is a thriving technique, radiation free and with a low complications rate. Presence of DCS, male sex or 2 simultaneous indications for VUS increase the probability of presenting VUR.


Subject(s)
Vesico-Ureteral Reflux , Child , Humans , Male , Infant , Adolescent , Vesico-Ureteral Reflux/diagnostic imaging , Reproducibility of Results , Cross-Sectional Studies , Contrast Media , Urination , Ultrasonography/methods
2.
Arch. esp. urol. (Ed. impr.) ; 75(8): 693–-699, 28 sept. 2022. tab, graf
Article in English | IBECS | ID: ibc-212095

ABSTRACT

Introduction: Voiding urosonography (VUS) is a dynamic imaging technique which evaluates the lower urinary tract by introducing sonographic contrast into the bladder, preferably used in the diagnosis of vesicoureteral reflux (VUR). Our goals were to describe the clinical indications for performing a VUS for VUR’s diagnosis and analyse its diagnostic reliability. Material and Methods: Cross-sectional study carried on patients under 15 years old with a VUS taken between November 2013-2020. Sex, age, indications (lower urinary tract infection—LUTI; dilatated lower urinary tract—DLUT; duplex collecting system—DCS), results (presence/absence of VUR, score and side) and complications were analysed. U Mann-Whitney and Chi-squared tests were used and 2 predictive capacity models for the indications used to detect VUR were employed (logistic binomial regression and multilayer perceptron neural network). Statistical significance p < 0.05. Results: 415 VUS were completed correctly (male 51.8%, median age 7.3 (3.1-15.3) months). Indications were: LUTI (67.5%), DLUT (33.5%) and DCS (10.2%); presenting 1, 2 and 3 indications in 86.5%, 12.8% and 0.7% respectively. VUR was diagnosed in 34.7% cases. A tendency towards statistically significance was showed related to male sex (p = 0.052) and the only significative clinical indication for VUR was DCS (p = 0.007). Patients with 2 simultaneous indications had higher probability of VUR (p = 0.012). DCS presence or male sex were the only predictive variables of VUR: DCS = OR 1.89 (1.54-6.52) (p = 0.006) and male sex = OR 1.56 (1.03-2.35) (p = 0.035). Conclusions: VUS is a thriving technique, radiation free and with a low complications rate. Presence of DCS, male sex or 2 simultaneous indications for VUS increase the probability of presenting VUR (AU)


Subject(s)
Humans , Male , Female , Infant , Vesico-Ureteral Reflux/diagnostic imaging , Ultrasonography/methods , Reproducibility of Results , Retrospective Studies , Contrast Media
3.
Arch Esp Urol ; 75(4): 318-324, 2022 May 28.
Article in English | MEDLINE | ID: mdl-35818911

ABSTRACT

OBJECTIVE: To analyse the clinical evolution, the therapeutic strategies and the characteristics of the patients presenting enuresis attended at our outpatient clinic. MATERIAL AND METHODS: Retrospective study of patients <14 years old(yo) diagnosed of enuresis attended at our outpatient clinic (2011-2019) and completed their follow-up (remission or aged 15). Urotherapy was offered to all patients as initial management. The therapeutic strategies were classified as: first line (desmopressin or clock alarm), second line (desmo-pressin+alarm) and third line(anticholinergics). The remission rate during follow-up, the number of consultations needed until remission and the treatments used were calculated. Statistical tests used:Kaplan-Meier, actuarial survival. Multivariate analysis:Cox regression.Statistical significance:p<0.05. RESULTS: Data were collected from 125 patients (mean age: 8.6±2.45yo). Family history of enuresis was present in 38.9%. The mean follow-up was 2.37±1.55yo and the average number of consultations was 7.54±5.06. The remission rate (RE) was 84%(n=105), with a median remission interval:2.66 years (2.34-2.991[95%CI]). The average number of treatments required for remission was 2.74±1.27. RE with urotherapy alone was 20%(n=25); RE with first line:19.3%(n=17) and second line:16.7(n=11). In the remaining patients, a RE of 78.18%(n=43) was achieved by adding an anticholinergic. Patients aged > 8.7 years at the beginning of the follow-up required less time to achieve remission (p=.025). These patients had a higher RE (hazard ratio 1.15 (1.05-1.25))(p=.004). No other variables were significant. CONCLUSION: Staged therapeutic strategies are necessary to achieve remission. Only 25% remitted with urotherapy as single treatment. RE are higher when patients are >8.7 yo once they initiate their follow up.


Subject(s)
Nocturnal Enuresis , Urinary Incontinence , Urology , Adolescent , Child , Deamino Arginine Vasopressin/therapeutic use , Humans , Retrospective Studies
4.
J Pediatr Urol ; 16(2): 218.e1-218.e6, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32044256

ABSTRACT

INTRODUCTION: Nutcracker syndrome (NS) defines an entity generated by the compression of the left renal vein resulting in venous hypertension, which transmitted in a retrograde direction may cause hematuria, proteinuria, and varicocele. The literature concerning exclusively pediatric patients is very rare. OBJECTIVE: To report the authors' experience with pediatric NS in the last 18 years. STUDY DESIGN: This is a retrospective review of the patients followed up in the authors' center with diagnosis of NS based on clinical and imaging tests (ultrasound, computed tomography/magnetic resonance imaging, and phlebography). The primary outcome was the success of the conservative approach in the study patients. RESULTS AND DISCUSSION: A total of 21 patients were diagnosed with NS and followed up for a mean period of 52.3 months (37.1-67.5). The mean age at diagnosis was 11.7 years (9.9-13.4). The most frequent symptom of presentation was hematuria in 16 patients (76.2%), being macroscopic in 75% patients and related to physical exercise in 42.9% patients. Other symptoms were left varicocele in 7 patients (33%) and proteinuria in 6 patients (28.6%). Mild to moderate cases received conservative treatment (change of physical activity, postural hygiene), which achieved resolution of symptoms in 16 patients (76.2%). Five cases (23.8%) finally needed a more aggressive approach. Two (9.5%) of them required endovascular procedures (intravascular stent in the renal vein in 1 case and embolization of the spermatic vein in 1 case); in one (4.8%) of the patients, transposition of the left renal vein and kidney autotransplantation were performed, and 2 (9.5%) of the patients with mild cases required surgical correction of the varicocele. CONCLUSIONS: Hematuria, usually macroscopic and related to physical exercise, is the most frequent symptom in pediatric patients with NS. The authors advocate studying the aortomesenteric junction by abdominal ultrasound in patients with varicocele or with intermittent macroscopic hematuria. Diagnosis is based on non-invasive tests; phlebography should be reserved for severe cases that require an interventionist attitude. A long period of conservative treatment is the first approach for pediatric patients with NS.


Subject(s)
Renal Nutcracker Syndrome , Varicocele , Child , Hematuria/etiology , Humans , Male , Renal Nutcracker Syndrome/diagnosis , Renal Nutcracker Syndrome/diagnostic imaging , Renal Veins/diagnostic imaging , Retrospective Studies , Varicocele/diagnostic imaging , Varicocele/therapy
5.
Arch Esp Urol ; 64(9): 897-903, 2011 Nov.
Article in English, Spanish | MEDLINE | ID: mdl-22155878

ABSTRACT

OBJECTIVE: To determine the utility of prostate ultrasound in the diagnosis of infravesical obstruction (IVO) and detrusor hyperactivity(DH). METHODS: Prospective study with 39 patients consulting for LUTS. Clinical history was compiled, IPSS was determined, a digital rectal exam was performed, abdominal ultrasound was used to calculate detrusor thickness/weight, prostate volume, and middle lobe length (MLL). Urodynamic study (UD) was performed with determination of the Abrams-Griffiths number and ICS nomogram. Mean values were compared with Mann-Whitney U-test, and ROC curves were plotted determining the cutoff points for optimum sensitivity/specificity. RESULTS: Mean age was 63.1 years (SD: 7.8), with a mean IPSS score of 14 (SD: 6). 53.8% of the patients presented IVO at UD evaluation, and 43.6% DH. The differences between free flowmetry Qmax(p=0.015) and MLL (p=0.003) between patients with and without IVO proved significant. The ROC curves yielded an AUC for middle lobe length of 0.772, with a maximum sensitivity and specificity cutoff point at 10.5 mm (sensitivity 90%, specificity 73%, PPV 76%, NPV 85%). There were no significant differences in any parameter between patients with and without DH. CONCLUSION: Ultrasound MLL measurement in patients with LUTS offers high sensitivity/specificity in diagnosing IVO, with a cutoff point of 10.5 mm. In our study it wasn't effective in the noninvasive diagnosis of DH.


Subject(s)
Prostate/diagnostic imaging , Urinary Bladder Neck Obstruction/diagnostic imaging , Urinary Bladder, Overactive/diagnostic imaging , Urinary Bladder/diagnostic imaging , Humans , Male , Middle Aged , Predictive Value of Tests , Prospective Studies , Prostatic Hyperplasia/complications , Sensitivity and Specificity , Ultrasonography , Urinary Bladder Neck Obstruction/complications , Urinary Bladder, Overactive/complications
6.
Arch. esp. urol. (Ed. impr.) ; 64(9): 897-903, nov. 2011. ilus, graf, tab
Article in Spanish | IBECS | ID: ibc-92329

ABSTRACT

OBJETIVO: Determinar la utilidad de la ecógrafía prostática para el diagnóstico de obstrucción infravesical(OIV) y del detrusor hiperactivo(DH).MÉTODOS: Estudio prospectivo sobre 39 pacientes que consultaron por STUI. Se realizó historia clínica, IPSS, tacto rectal, ecografía abdominal midiendo grosor del detrusor, peso del detrusor, volumen prostático, longitud lóbulo medio(LLM) y estudio urodinámico (EUD) con obtención del número de Abrams-Griffiths y nomograma ICS. Se compararon medias con el test de U Mann-Whitney y se construyeron curvas ROC determinando los puntos de corte óptimos de sensibilidad y especificidad, con una significación estadística p < 0.05.RESULTADOS: La edad media de los 39 pacientes fue 63,1 años(DE:7,8 años) con IPSS medio de 14 puntos(DE:6) siendo la puntuación media de los síntomas de urgencia de 5,9 puntos(DE:3,1).El 53,8% de pacientes presentaron OIV en el EUD y el 43,6% DH. Resultaron significativas las diferencias entre el Qmax de la flujometría libre(p=0,015) y la LLM(p=0,003) entre los pacientes con OIV y los que no . Las curvas ROC mostraron un área bajo la curva para la LLM de 0,772 con punto de mayor sensibilidad y especificidad en 10,5mm(S:90%,E:73%,VPP:76%,VPN:85%). No hubieron diferencias en ningún parámetro entre pacientes con y sin DH.CONCLUSIONES: La medición de la LLM mediante ecografía en pacientes con STUI presenta una alta sensibilidad/especificidad para el diagnóstico de OIV con punto de corte 10,5mm. Es bien tolerada, económica y rápida. En nuestro estudio no se ha mostrado como una prueba eficaz en el diagnóstico no invasivo del hiperactividad del DH(AU)


OBJECTIVE: To determine the utility of prostate ultrasound in the diagnosis of infravesical obstruction (IVO) and detrusor hyperactivity(DH).METHODS: Prospective study with 39 patients consulting for LUTS. Clinical history was compiled, IPSS was determined, a digital rectal exam was performed, abdominal ultrasound was used to calculate detrusor thickness/weight, prostate volume, and middle lobe length (MLL). Urodynamic study (UD) was performed with determination of the Abrams-Griffiths number and ICS nomogram. Mean values were compared with Mann-Whitney U-test, and ROC curves were plotted determining the cutoff points for optimum sensitivity/specificity.RESULTS: Mean age was 63.1 years (SD: 7.8), with a mean IPSS score of 14 (SD: 6). 53.8% of the patients presented IVO at UD evaluation, and 43.6% DH. The differences between free flowmetry Qmax(p=0.015) and MLL (p=0.003) between patients with and without IVO proved significant. The ROC curves yielded an AUC for middle lobe length of 0.772, with a maximum sensitivity and specificity cutoff point at 10.5 mm (sensitivity 90%, specificity 73%, PPV 76%, NPV 85%). There were no significant differences in any parameter between patients with and without DH.CONCLUSION: Ultrasound MLL measurement in patients with LUTS offers high sensitivity/specificity in diagnosing IVO, with a cutoff point of 10.5 mm. In our study it wasn’t effective in the noninvasive diagnosis of DH(AU)


Subject(s)
Humans , Urinary Bladder, Overactive , Prostatic Hyperplasia/complications , Urinary Bladder, Overactive/etiology , Prostatic Hyperplasia , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL